“We chose to partner with Medidata because we recognize that we need an innovative technology partner with deep understanding of CROs and sites and sponsors in order for us to excel in this market. Medidata delivers the right platform, expertise and services that will allow us to be competitive and …

"When compared with traditional cardiovascular trials that engage hundreds or thousands of sites, this technology allowed us to enroll 15,000 participants from 40 centers. We think this infrastructure and approach will facilitate studies that can be direct-to-patient, easier for patients and investigators, and faster to completion."

“Medidata is a valued and trusted partner. We use a range of their solutions which have allowed us to manage various unique and complex study requirements without having to use custom programming. This has ensured consistent and efficient trial execution.”

“A shared culture is the key to any successful partnership – Medidata’s commitment to integrity and to putting the client at the center of its work aligns perfectly with palleos’ values.”

“Medidata AI literally rolled up their sleeves, helped us analyze the data, and suggested ways to improve our clinical trial design. They were essentially part of our statistical group. We worked with Medidata and leveraged that information when we went to the FDA.”

"We eliminated double data entry at the medical institution and were able to improve efficiency in clinical trial data capture."

"The Medidata products are very innovative and support our very complex oncology studies."

"We didn’t go shopping, we knew we wanted to use Medidata and it was a matter of working to find the right study build model to fit our business needs.”

“We used to do all the reconciliation manually. With the Rave Site Payment, it’s automated the payments not only from a sponsor’s perspective but also from the site’s perspective. Sites don’t have to do anything additional. From a sponsor perspective, we have all the line item details. We can see …

“Having our documentation in a secure, validated environment enables an ease of use for authoring, review, and approval. This allows us to pay attention to other things so we can focus on our product development.”

“It is to everyone’s advantage to [use Medidata’s] unified platform so that there is one login. There is one way that people are accessing all the things they need to do with their data. If we’re thinking of patients and sites first, we have to think about that value…[so] they’re …

“Our partnership with Medidata has enabled us to offer top-notch service to sponsors. In the last decade, we’ve embraced the latest Rave EDC technology, including eCOA/ePRO via the Patient Cloud and Rave Coder. We’ve successfully configured intricate study designs, from early-phase oncology with numerous protocol changes to rare disease studies …

“Medidata’s choice to implement the Rave eCOA/ ePRO solution in a unified environment with Rave EDC allows the user to extend their study design knowledge and ease the ePRO design, especially for beginners.“

"Since Medidata developed the web services on the open operational data model (ODM) standard, Spaulding can rapidly apply integration designs to other studies and sponsors."

“Medidata is a global brand that everyone knows, and everyone is happy to use. The seamless experience … creates a much easier experience for us. Sites are entering data very quickly. They know the system and they know these modules back and forth. They don’t have a lot of questions. …